Home » Topics » BioWorld Science

BioWorld Science
RSS

Xoc Pharmaceuticals presents phase I data for XC101-D13H in preventing migraine

June 18, 2020

GlaxoSmithKline and collaborators identify NF-kappaB activators/HIV latency-reversing agents

June 18, 2020

Merck & Co. patents IDO-1 inhibitors

June 18, 2020

Novartis describes new PCSK9 inhibitors

June 18, 2020

New MALT1 inhibitors discovered at Takeda

June 18, 2020

Otsuka Pharmaceutical presents new antiseizure compounds

June 18, 2020

First clinical results presented for PXS-5505

June 18, 2020

Safety run-in results from phase I/II study of VXM-01 plus avelumab in progressive glioblastoma

June 18, 2020

Encouraging interim data presented from phase II/III study of IFX-1 in severe COVID-19

June 18, 2020

Dare Bioscience initiates pivotal phase III study of DARE-BV1 in bacterial vaginosis

June 18, 2020

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...